January 2026 in “RSC Advances” Epristeride's metabolism in zebrafish helps improve doping detection methods.
91 citations
,
July 2004 in “Journal of Biological Chemistry” Overexpressing SSAT enzyme reduces prostate tumor growth in mice.
Teprotumumab for thyroid eye disease commonly causes fatigue, brittle nails, dry eyes, hair loss, muscle spasms, and dry mouth, with rare serious events like blood clots.
108 citations
,
April 2004 in “Medicinal Research Reviews” Steroid sulfatase inhibitors could help treat hormone-related disorders and cancers.
54 citations
,
July 1967 in “Science” Decomposed tritiated thymidine is less accurate for DNA tracing, and hair changes can indicate malnutrition.
October 2025 in “Biomedicines” Terminalia chebula fruit extract helps hair growth by reducing DHT and boosting hair cell activity.
51 citations
,
December 2003 in “The FASEB Journal” The substance AS101 can help hair grow by slowing down hair cell aging and boosting a hair growth protein.
16 citations
,
November 2023 in “Scientific Reports” The niosomes effectively target hair follicles for acne treatment.
October 2023 in “Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy” New, eco-friendly methods accurately measure TDF and FNS in a new urologic medication.
UBC13 and UBC22 enzymes are important for plant growth and development in Arabidopsis thaliana.
12 citations
,
November 2014 in “Bioscience, Biotechnology, and Biochemistry” Genetically modifying a bacteria and changing its growth conditions significantly increased the production of a chemical called dipicolinic acid.
4 citations
,
January 1993 in “Clinical Chemistry and Laboratory Medicine (CCLM)” The new method is 1000 times more sensitive for measuring hair growth.
33 citations
,
August 1993 in “FEBS Letters” A new enzyme in rats may help regulate hair growth.
Topical GT20029 effectively promotes hair regrowth and is well-tolerated.
25 citations
,
January 2017 in “Steroids” Allopregnanolone increases growth and changes gene activity in human brain cancer cells.
January 2019 in “Oncogen” Triple Hormonal Blockade (ADT3) can effectively manage prostate cancer but requires careful monitoring for heart risks.
6 citations
,
March 1996 in “Journal of Investigative Dermatology”
July 2025 in “Journal of Investigative Dermatology” 5% ET-02 is a more effective and safe treatment for hair loss than current options.
198 citations
,
October 1986 in “Differentiation” 4 citations
,
July 2023 in “Frontiers in Microbiology” HGF combined with ADA is highly accurate for diagnosing tuberculous pleural effusion, especially in younger females.
148 citations
,
October 1997 in “Journal of Investigative Dermatology”
July 2022 in “International Journal of Trichology” Tofacitinib helped an 8-year-old child recover from a type of hair loss that is hard to treat.
13 citations
,
October 2017 in “Bioorganic & Medicinal Chemistry” Optimizing the structure of a specific compound greatly improved its effectiveness and precision for treating diabetic complications.
188 citations
,
June 1998 in “Molecular cell” Researchers created a mouse with the same mutation as humans with trichothiodystrophy, showing similar symptoms and confirming the condition is due to defects in DNA repair and gene activity.
28 citations
,
June 2023 in “Tissue Engineering and Regenerative Medicine” ETS2 drives cancer progression in squamous cell carcinoma and is linked to poor patient outcomes.
May 2019 in “Asian Journal of Chemistry” Finasteride forms three new products under acidic stress.
July 2025 in “Ultrasound in Medicine & Biology” The study explores a novel combination therapy using ultrasound-targeted microbubble destruction (UTMD) with nanobubble-encapsulated diclofenac (DNBs) to enhance tumor immunotherapy. This approach improves the tumor immune microenvironment by reducing lactate secretion and immunosuppressive cells, while increasing the uptake of Doxil® and promoting T cell responses. The therapy significantly decreases M2 tumor-associated macrophages to 22% and myeloid-derived suppressor cells to 5.3%, while increasing CD8+ T cells to 51.1% and CD4+ T cells to 24.1%, resulting in a synergistic anti-tumor effect. Although the study is limited by its use of a single mouse cancer model and technical challenges, it offers promising insights for improving cancer treatment by modulating the tumor microenvironment and enhancing immune responses.
215 citations
,
November 2000 in “Journal of Investigative Dermatology” The system allows precise control of gene expression in mouse skin, useful for studying skin biology.
May 2024 in “Archives of Dermatological Research” TAT-GILZ peptide promotes hair growth by boosting stem cell activity.